Melanoma treatment in Germany follows a multidisciplinary approach focused on surgical excision and advanced systemic therapies. Key methods include wide local excision with safety margins, sentinel lymph node biopsy, and immunotherapy using PD-1 inhibitors. Leading German centers provide personalized treatments like dendritic cell vaccines and BRAF-targeted therapies.
- Surgical excision: Standard first-line treatment involving tumor removal with 0.5 to 2 cm margins.
- Mohs microsurgery: Specialized tissue-sparing technique used for melanoma in cosmetically sensitive facial areas.
- Systemic immunotherapy: Use of pembrolizumab or nivolumab to help the immune system attack cancer.
- Targeted therapy: Employs BRAF and MEK inhibitors for patients with specific genetic mutations.
Bookimed Expert Insight: German oncology centers like Nordwest Clinic and Asklepios Hospital Barmbek integrate specialized anticancer vaccines directly into their targeted therapy protocols. While many global centers focus solely on standard drugs, these institutions utilize internal research institutes to customize individual antitumor vaccines. This approach is particularly effective for high-volume centers, with some facilities treating over 110,000 patients annually.
Patient Consensus: Patients note that getting BRAF and NRAS genotyping early is essential to unlock specific targeted drug options. They also emphasize the importance of a multidisciplinary tumor board review for any stage III or higher diagnosis.
